359 related articles for article (PubMed ID: 23729265)
21. Structure-based computational approaches for small-molecule modulation of protein-protein interactions.
Xu D; Wang B; Meroueh SO
Methods Mol Biol; 2015; 1278():77-92. PubMed ID: 25859944
[TBL] [Abstract][Full Text] [Related]
22. Development of a rule-based method for the assessment of protein druggability.
Perola E; Herman L; Weiss J
J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
[TBL] [Abstract][Full Text] [Related]
23. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deniz U; Ozkirimli E; Ulgen KO
J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
[TBL] [Abstract][Full Text] [Related]
24. Negative Image-Based Screening: Rigid Docking Using Cavity Information.
Postila PA; Kurkinen ST; Pentikäinen OT
Methods Mol Biol; 2021; 2266():125-140. PubMed ID: 33759124
[TBL] [Abstract][Full Text] [Related]
25. Protein pharmacophore selection using hydration-site analysis.
Hu B; Lill MA
J Chem Inf Model; 2012 Apr; 52(4):1046-60. PubMed ID: 22397751
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
[TBL] [Abstract][Full Text] [Related]
27. Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors.
Sakkiah S; Thangapandian S; John S; Lee KW
Eur J Med Chem; 2011 Jul; 46(7):2937-47. PubMed ID: 21531051
[TBL] [Abstract][Full Text] [Related]
28. Charting a Path to Success in Virtual Screening.
Forli S
Molecules; 2015 Oct; 20(10):18732-58. PubMed ID: 26501243
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing.
Ge H; Wang Y; Li C; Chen N; Xie Y; Xu M; He Y; Gu X; Wu R; Gu Q; Zeng L; Xu J
J Chem Inf Model; 2013 Oct; 53(10):2757-64. PubMed ID: 24001302
[TBL] [Abstract][Full Text] [Related]
30. Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors.
Xue X; Wei JL; Xu LL; Xi MY; Xu XL; Liu F; Guo XK; Wang L; Zhang XJ; Zhang MY; Lu MC; Sun HP; You QD
J Chem Inf Model; 2013 Oct; 53(10):2715-29. PubMed ID: 24050442
[TBL] [Abstract][Full Text] [Related]
31. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
32. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
Ahmadi M; Nowroozi A; Shahlaei M
J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
[TBL] [Abstract][Full Text] [Related]
33. Beware of machine learning-based scoring functions-on the danger of developing black boxes.
Gabel J; Desaphy J; Rognan D
J Chem Inf Model; 2014 Oct; 54(10):2807-15. PubMed ID: 25207678
[TBL] [Abstract][Full Text] [Related]
34. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
[TBL] [Abstract][Full Text] [Related]
35. Use of experimental design to optimize docking performance: the case of LiGenDock, the docking module of LiGen, a new de novo design program.
Beato C; Beccari AR; Cavazzoni C; Lorenzi S; Costantino G
J Chem Inf Model; 2013 Jun; 53(6):1503-17. PubMed ID: 23590204
[TBL] [Abstract][Full Text] [Related]
36. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
Kurczab R; Bojarski AJ
J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
[TBL] [Abstract][Full Text] [Related]
37. An integrated virtual screening approach for VEGFR-2 inhibitors.
Zhang Y; Yang S; Jiao Y; Liu H; Yuan H; Lu S; Ran T; Yao S; Ke Z; Xu J; Xiong X; Chen Y; Lu T
J Chem Inf Model; 2013 Dec; 53(12):3163-77. PubMed ID: 24266594
[TBL] [Abstract][Full Text] [Related]
38. Methods for predicting protein-ligand binding sites.
Xie ZR; Hwang MJ
Methods Mol Biol; 2015; 1215():383-98. PubMed ID: 25330972
[TBL] [Abstract][Full Text] [Related]
39. Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors.
Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
J Mol Graph Model; 2012 Sep; 38():123-36. PubMed ID: 23079643
[TBL] [Abstract][Full Text] [Related]
40. Automated ligand- and structure-based protocol for in silico prediction of human serum albumin binding.
Hall ML; Jorgensen WL; Whitehead L
J Chem Inf Model; 2013 Apr; 53(4):907-22. PubMed ID: 23472823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
